Prevention of Rh-haemolytic disease.
D000917:Antibody Formation; D001787:Blood Group Incompatibility / Q000276:immunology; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000517:prevention & control*; D005719:gamma-Globulins / Q000627:therapeutic use*
D005719:gamma-Globulins